Member of the Hungarian Academy of Sciences, internationally recognized expert in 3D bioprinting and organoid technologies. Originally trained as a theoretical physicist, he later turned to biophysics, focusing on the interplay between genetic and physical processes during early embryonic development. He is a pioneer in human cell–based 3D tissue and liver model development, and a scientific founder or co-founder of several biotech companies. In 2007, he co-founded Organovo, the world’s first commercial bioprinting company, building on bioprinting technology developed in his academic lab at the University of Missouri. Since 2011, he has also served as scientific founder of Modern Meadow. His innovations have contributed to the development of tissue-engineered platforms for drug testing and therapeutic applications. More recently, he has focused on applying 3D bioprinting to the production of cell-based animal products such as skin and meat, with the aim of reducing environmental impact and resource use in traditional industries.